Cover Image

The use of secukinumab in patients with chronic infections

Saved in:

Bibliographic Details
Main Authors:	Hamza Malick (Author), Zaryab Alam (Author), Kyle C. Lauck (Author), Dario Kivelevitch (Author)
Format:	Book
Published:	Wiley, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date
by: Kivelevitch D, et al.
Published: (2019)

Secukinumab-induced chronic discoid lupus erythematosus
by: Giannis Chatzimichail, MD, et al.
Published: (2020)

Secukinumab
by: Nilgün Atakan
Published: (2022)

Widespread superficial dermatophytosis in patient on secukinumab for treatment of chronic plaque psoriasis
by: Shekhar Neema, et al.
Published: (2019)

Successful use of secukinumab in Netherton syndrome
by: Sarah K. Blanchard, MD, et al.
Published: (2020)

Nonscarring Alopecia Secondary to Secukinumab
by: L.L. Tirelli, et al.
Published: (2022)

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
by: Alessio Gambardella
Published: (2019)

Secukinumab in the treatment of psoriasis: patient selection and perspectives
by: Yang EJ, et al.
Published: (2018)

A Case of Granuloma Annulare Associated with Secukinumab Use
by: Lauren Bonomo, et al.
Published: (2017)

Secukinumab for recalcitrant chronic plaque psoriasis in a 9 year old child
by: R Shruthi, et al.
Published: (2021)

Secukinumab‐induced lichen planus
by: Jihane Belcadi, et al.
Published: (2024)

Secukinumab in generalized pustular psoriasis
by: Shraddha Madanagobalane
Published: (2018)

Secukinumab Therapy in Psoriasis Management
by: Ira Yunita, et al.
Published: (2022)

Granuloma Annulare in the Setting of Secukinumab
by: Matthew L. Clark, et al.
Published: (2018)

Secukinumab Associated Choroidal Neovascularization
by: Edward B Miller, et al.
Published: (2022)

Secukinumab-Induced Lymphocytic Colitis
by: Siva Santosh Kumar Gandu MD, et al.
Published: (2022)

Secukinumab for Psoriasis in Obese Patients: Minireview and Clinical Experience
by: Rossana Tiberio, et al.
Published: (2019)

Changes in metabolic parameters in psoriatic patients treated with secukinumab
by: Hsuan Ning Wang, et al.
Published: (2020)

Real-Life Experience of Secukinumab in Patients With Hidradenitis Suppurativa
by: F.J. Melgosa Ramos, et al.
Published: (2023)

Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis
by: Stefano Gentileschi, et al.
Published: (2020)

Secukinumab: supervivencia en práctica clínica real
by: R. Ruiz-Villaverde, et al.
Published: (2021)

Asymptomatic microscopic colitis induced by secukinumab
by: Matteo Megna, MD, et al.
Published: (2024)

Secukinumab treatment of Parry-Romberg syndrome
by: Emily Sideris, MBBS, BA, LLB, et al.
Published: (2020)

The significance of secukinumab in the treatment of plaque psoriasis
by: Marta Kasprowicz-Furmańczyk, et al.
Published: (2022)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
by: Lubrano E, et al.
Published: (2016)

Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
by: Simone Ribero, et al.
Published: (2019)

Paradoxical pustular psoriasis in a patient with spondyloarthritis treated with secukinumab
by: Daniela Anghel, et al.
Published: (2023)

Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
by: Elena Conesa-Nicolás, et al.
Published: (2021)

[Articulo traducio] Alopecia no cicatricial secundaria a secukinumab
by: L.L. Tirelli, et al.
Published: (2022)

Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
by: Zhang C, et al.
Published: (2023)

Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement
by: G. Adami, et al.
Published: (2023)

New-Onset Blepharitis in a Patient Treated With Secukinumab for Severe Psoriasis
by: Maria Francesca Baracca, et al.
Published: (2024)

Secukinumab in psoriasis: A single-center experience
by: Esra Ağaoğlu, et al.
Published: (2021)

Secukinumab-induced paradoxical palmoplantar pustular psoriasis
by: Yıldız Gürsel Ürün, et al.
Published: (2022)

Promising results with secukinumab in refractory pediatric psoriasis
by: Sukriti Baveja, et al.
Published: (2020)

Profile of secukinumab in the treatment of psoriasis: current perspectives
by: Roman M, et al.
Published: (2015)

Effects of secukinumab on serum adipocytokines: preliminary data
by: A. Fassio, et al.
Published: (2017)

Secukinumab Therapy in Refractory Juvenile Idiopathic Arthritis
by: Meghan Corrigan Nelson DO, et al.
Published: (2023)

Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
by: Amy J. Petty, BS, et al.
Published: (2020)

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
by: Jashin J. Wu, et al.
Published: (2020)